Jefferies Group’s DexCom DXCM Stock Holding History

Jefferies Group’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-40,800	Closed	-$3.77M	–	1712
2020 Q4	$3.77M	Buy	+40,800	New	+$3.64M	0.03%	504
2018 Q4	–	Sell	-87,600	Closed	-$3.13M	–	2237
2018 Q3	$3.13M	Buy	87,600 +47,600	+119%	+$1.48M	0.02%	766
2018 Q2	$950K	Buy	+40,000	New	+$848K	0.01%	1297
2016 Q4	–	Sell	-68,800	Closed	-$1.51M	–	2261
2016 Q3	$1.51M	Hold	68,800	–	–	0.01%	1068
2016 Q2	$1.36M	Buy	+68,800	New	+$1.17M	0.01%	1032

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jefferies Group's DXCM Position: Q3 2022 in Review

Jefferies Group opened a new position in DexCom (DXCM) in Q3 2022: 9,516 shares worth $766K. The stake represents 0.01% of the portfolio and ranks #882 among its holdings. This is a return to the name: Jefferies Group previously reported a position in DXCM as recently as Q1 2022.

Jefferies Group first reported a position in DXCM in Q4 2013 and has held it in 21 quarters since. The position peaked at $28.5M in Q3 2021. 794 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

Jefferies Group held 9,516 shares of DexCom worth $766K as of Q3 2022.
DexCom was a new Jefferies Group position in Q3 2022.
DexCom made up 0.01% of Jefferies Group's portfolio in Q3 2022, its #882 holding.
Jefferies Group first reported a position in DexCom in Q4 2013 and has held it in 21 quarters since.
Jefferies Group's DexCom position peaked at $28.5M in Q3 2021.
794 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.